0001728117-21-000064.txt : 20210610
0001728117-21-000064.hdr.sgml : 20210610
20210610195420
ACCESSION NUMBER: 0001728117-21-000064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210609
FILED AS OF DATE: 20210610
DATE AS OF CHANGE: 20210610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniel Thomas O
CENTRAL INDEX KEY: 0001538894
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 211009598
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_162336924416710.xml
FORM 4
X0306
4
2021-06-09
0
0001728117
Gossamer Bio, Inc.
GOSS
0001538894
Daniel Thomas O
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
8.97
2021-06-09
4
A
0
23500
0
A
2031-06-08
Common Stock
23500.0
23500
D
The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
/s/ Jeff Boerneke, Attorney-in-Fact
2021-06-10